scholarly article | Q13442814 |
P2093 | author name string | Zhi-Hua Yang | |
Jin-Qun Hu | |||
Yang-Fu Jiang | |||
P2860 | cites work | Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 |
Tumor angiogenesis: therapeutic implications | Q27860595 | ||
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis | Q34210479 | ||
The implications of angiogenesis for the biology and therapy of cancer metastasis | Q40394139 | ||
Molecular aspects of tumor cell invasion and metastasis | Q40877783 | ||
Complex roles of matrix metalloproteinases in tumor progression. | Q41117062 | ||
Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis | Q41140259 | ||
Clinical research advances in primary liver cancer | Q43073158 | ||
Expression of a multidrug resistance gene in human cancers | Q69366790 | ||
Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study | Q73857003 | ||
[Multivariate analysis of prognostic factors after hepatectomy for primary liver cancer] | Q77600014 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | angiogenesis inhibitor | Q574834 |
P304 | page(s) | 61-65 | |
P577 | publication date | 2000-02-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Recurrence or metastasis of HCC:predictors, early detection and experimental antiangiogenic therapy | |
P478 | volume | 6 |
Q36397376 | Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection |
Q30724233 | Anti-hepatoma activity of resveratrol in vitro |
Q34382968 | Antitumor and antiangiogenic activities of anti-vascular endothelial growth factor hairpin ribozyme in human hepatocellular carcinoma cell cultures and xenografts. |
Q36308239 | Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody |
Q41983590 | Construction and expression of recombined human AFP eukaryotic expression vector |
Q55195864 | Coordination of FOXA2 and SIRT6 suppresses the hepatocellular carcinoma progression through ZEB2 inhibition. |
Q33241639 | Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma |
Q40697710 | DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line |
Q41840983 | DSA analysis of hepatic arteriovenous fistula concurrent with hepatic cancer and its clinical significance. |
Q36308387 | Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells |
Q31039293 | Expression of liver cancer associated gene HCCA3. |
Q34795631 | FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma |
Q36308500 | Field population-based blocking treatment of esophageal epithelia dysplasia |
Q36178624 | Gene expression profiles of hepatoma cell line HLE. |
Q64062932 | High expression of B7‑H2 or B7‑H3 is associated with poor prognosis in hepatocellular carcinoma |
Q94220643 | In Vitro Effect of Cytokines, Inducers, and Inhibitors on the Secretion of MMP-2 and MMP-9 in Hepatocarcinoma Cell Line SK-Hep-1 |
Q33183761 | Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats |
Q40741131 | Inhibitory effect of endostatin expressed by human liver carcinoma SMMC7721 on endothelial cell proliferation in vitro |
Q43159514 | Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell |
Q36316057 | Mechanical properties of hepatocellular carcinoma cells. |
Q37726407 | MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma |
Q39419949 | Micronutrient Synergy in the Fight against Hepatocellular Carcinoma |
Q36397228 | Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice. |
Q26851211 | Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development |
Q35158201 | Numb promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma |
Q36308536 | P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection |
Q36178307 | Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex |
Q36316052 | Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. |
Q36190630 | Preparation and characterization of polyclonal antibodies against ARL-1 protein |
Q36067470 | Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia |
Q36415730 | Relationship between genotype and phenotype of flagellin C in Salmonella. |
Q37107860 | SNF2H promotes hepatocellular carcinoma proliferation by activating the Wnt/β-catenin signaling pathway |
Q34501851 | Serum tumor markers for detection of hepatocellular carcinoma |
Q43119142 | Sleep deprivation increase the expression of inducible heat shock protein 70 in rat gastric mucosa. |
Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Q34582844 | The prognostic significance of clinical and pathological features in hepatocellular carcinoma |
Q35023159 | The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma |
Q37661438 | Toxic damage increases angiogenesis and metastasis in fibrotic livers via PECAM-1. |
Q81098236 | Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model |
Q47158378 | Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis |
Q36502592 | Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats. |
Search more.